Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pashna N. Munshi"'
Autor:
Asad Bashey, Mary Eapen, Melhem Solh, Sameh Gaballa, Kavita Raj, Mei-Jie Zhang, Vanderson Rocha, Rizwan Romee, Claudio Anasetti, Mehdi Hamadani, Robert J. Soiffer, Monzr M. Al Malki, Ephraim J. Fuchs, Miguel-Angel Perales, Pashna N. Munshi, Ryotaro Nakamura, Omotayo Fasan, Shannon R. McCurdy, Trevor Argall, Rachel B. Salit, Stefan O. Ciurea, Scott D. Rowley, Andrew St. Martin, Paul O'Donnell
Publikováno v:
Journal of Clinical Oncology. 35:3002-3009
Purpose T-cell–replete HLA-haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide was originally described using bone marrow (BM). With increasing use of mobilized peripheral blood (PB), we compared transplant out
Autor:
Ibrahim Yakoub-Agha, Henry Chi Hang Fung, David G. Maloney, Basem M. William, Javier Munoz, Sven de Vos, Alison R. Sehgal, Gilles Salles, Mauro P. Avanzi, Yin Yang, Jennifer Lee, Lori A. Leslie, Julio C. Chavez, Pashna N. Munshi, Ran Reshef, Olalekan O. Oluwole, Caron A. Jacobson, Vicki Plaks, Sattva S. Neelapu, Carla Casulo
Publikováno v:
Journal of Clinical Oncology. 39:7515-7515
7515 Background: POD24 is an indicator of poor survival in iNHL (Casulo & Barr. Blood. 2019). In the ZUMA-5 Phase 2 study of axi-cel anti-CD19 CAR T-cell therapy in pts with R/R iNHL, overall response rates (ORR) after 17.5 months median follow-up we
Autor:
Alison R. Sehgal, Sattva S. Neelapu, Vicki Plaks, Jennifer Lee, Julio C. Chavez, Gilles Salles, Yin Yang, Basem M. William, Carla Casulo, Caron A. Jacobson, Pashna N. Munshi, Sven de Vos, Ran Reshef, Olalekan O. Oluwole, Javier Munoz, Mauro P. Avanzi, Ibrahim Yakoub-Agha, David G. Maloney, Lori A. Leslie, Henry C. Fung
Publikováno v:
Publons
8008 Background: Advanced stage iNHL, including follicular lymphoma (FL) and marginal zone lymphoma (MZL), is considered incurable as most pts experience multiple relapses (Wang, et al. Ther Adv Hematol. 2017), highlighting a need for novel therapies